Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Bile Duct Neoplasms 3Jaundice 2Biliary Tract Neoplasms 2Neoplasms 1Hemobilia 1Gallbladder Neoplasms 1Fistula 1Cholestasis 1Cholangiocarcinoma 1Biliary Tract Diseases 1Bile Duct Diseases 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT03504293 2020-12-22

The Diagnostic Value of Combinatory EUS and ERCP in Unclear Lesions

Sahlgrenska University Hospital

Completed
90 enrolled
Gastrointestinal

Biliary Tract Diseases, Biliary Tract Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡